148 related articles for article (PubMed ID: 28186508)
21. Dementia is associated with open-angle glaucoma: a population-based study.
Chung SD; Ho JD; Chen CH; Lin HC; Tsai MC; Sheu JJ
Eye (Lond); 2015 Oct; 29(10):1340-6. PubMed ID: 26160529
[TBL] [Abstract][Full Text] [Related]
22. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
[TBL] [Abstract][Full Text] [Related]
23. COLORADO AGE-RELATED MACULAR DEGENERATION REGISTRY: Design and Clinical Risk Factors of the Cohort.
Lynch AM; Patnaik JL; Cathcart JN; Mathias MT; Siringo FS; Lacey Echalier E; Wagner BD; Oliver SCN; Pecen PE; Olson JL; Fine SL; Palestine AG; Mandava N
Retina; 2019 Apr; 39(4):656-663. PubMed ID: 29283981
[TBL] [Abstract][Full Text] [Related]
24. Risk of developing open-angle glaucoma in patients with carotid artery stenosis: A nationwide cohort study.
Chou CC; Hsu MY; Lin CH; Lin CC; Wang CY; Shen YC; Wang IJ
PLoS One; 2018; 13(4):e0194533. PubMed ID: 29684030
[TBL] [Abstract][Full Text] [Related]
25. Implementation studies of ranibizumab for neovascular age-related macular degeneration.
Bloch SB
Acta Ophthalmol; 2013 Nov; 91 Thesis7():1-22. PubMed ID: 24206851
[TBL] [Abstract][Full Text] [Related]
26. Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial.
Abdelfattah NS; Al-Sheikh M; Pitetta S; Mousa A; Sadda SR; Wykoff CC;
Ophthalmology; 2017 Feb; 124(2):215-223. PubMed ID: 27863845
[TBL] [Abstract][Full Text] [Related]
27. Phacoemulsification does not induce neovascular age-related macular degeneration.
Baatz H; Darawsha R; Ackermann H; Scharioth GB; de Ortueta D; Pavlidis M; Hattenbach LO
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1079-83. PubMed ID: 18326733
[TBL] [Abstract][Full Text] [Related]
28. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
[TBL] [Abstract][Full Text] [Related]
29. Risk of age-related macular degeneration 3 years after cataract surgery: paired eye comparisons.
Wang JJ; Fong CS; Rochtchina E; Cugati S; de Loryn T; Kaushik S; Tan JS; Arnold J; Smith W; Mitchell P
Ophthalmology; 2012 Nov; 119(11):2298-303. PubMed ID: 22959104
[TBL] [Abstract][Full Text] [Related]
30. New neovascular age-related macular degeneration is associated with systemic leucocyte activity.
Subhi Y; Lykke Sørensen T
Acta Ophthalmol; 2017 Aug; 95(5):472-480. PubMed ID: 27860298
[TBL] [Abstract][Full Text] [Related]
31. Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States.
Gower EW; Stein JD; Shekhawat NS; Mikkilineni S; Blachley TS; Pajewski NM
Am J Ophthalmol; 2017 Dec; 184():157-166. PubMed ID: 29106914
[TBL] [Abstract][Full Text] [Related]
32. Hypothyroidism and the risk of developing open-angle glaucoma: a five-year population-based follow-up study.
Lin HC; Kang JH; Jiang YD; Ho JD
Ophthalmology; 2010 Oct; 117(10):1960-6. PubMed ID: 20557938
[TBL] [Abstract][Full Text] [Related]
33. Albuminuria Is Associated with Open-Angle Glaucoma in Nondiabetic Korean Subjects: A Cross-Sectional Study.
Kim GA; Park SH; Ko J; Lee SH; Bae HW; Seong GJ; Kim CY
PLoS One; 2016; 11(12):e0168682. PubMed ID: 28006020
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for open-angle glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey.
Kyari F; Abdull MM; Wormald R; Evans JR; Nolan W; Murthy GV; Gilbert CE;
BMC Ophthalmol; 2016 Jun; 16():78. PubMed ID: 27267038
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and risk factors of age-related macular degeneration in Korea: the Korea National Health and Nutrition Examination Survey 2010-2011.
Cho BJ; Heo JW; Kim TW; Ahn J; Chung H
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1101-8. PubMed ID: 24204048
[TBL] [Abstract][Full Text] [Related]
36. Plasma Homocysteine and Asymmetrical Dimethyl-l-Arginine (ADMA) and Whole Blood DNA Methylation in Early and Neovascular Age-Related Macular Degeneration: A Pilot Study.
Pinna A; Zinellu A; Tendas D; Blasetti F; Carru C; Castiglia P
Curr Eye Res; 2016; 41(1):88-96. PubMed ID: 25611924
[TBL] [Abstract][Full Text] [Related]
37. C-reactive protein and the incidence of macular degeneration: pooled analysis of 5 cohorts.
Mitta VP; Christen WG; Glynn RJ; Semba RD; Ridker PM; Rimm EB; Hankinson SE; Schaumberg DA
JAMA Ophthalmol; 2013 Apr; 131(4):507-13. PubMed ID: 23392454
[TBL] [Abstract][Full Text] [Related]
38. Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients.
Alexander SL; Linde-Zwirble WT; Werther W; Depperschmidt EE; Wilson LJ; Palanki R; Saroj N; Butterworth SL; Ianchulev T
Ophthalmology; 2007 Dec; 114(12):2174-8. PubMed ID: 18054636
[TBL] [Abstract][Full Text] [Related]
39. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.
Kikuchi M; Nakamura M; Ishikawa K; Suzuki T; Nishihara H; Yamakoshi T; Nishio K; Taki K; Niwa T; Hamajima N; Terasaki H
Ophthalmology; 2007 Sep; 114(9):1722-7. PubMed ID: 17400294
[TBL] [Abstract][Full Text] [Related]
40. Association of Open-Angle Glaucoma with Non-Alzheimer's Dementia and Cognitive Impairment.
Umunakwe O; Gupta D; Tseng H
Ophthalmol Glaucoma; 2020; 3(6):460-465. PubMed ID: 32830102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
